Clear cell borderline tumor without fibromatous component: Pathological and literature review and report of two cases
article
OA: diamond
CC0
⤵ 1 in-corpus citation
Abstract
The aim of the present study was to examine the clinical outcome of ovarian clear cell borderline tumor (CCBT) through pathological review for cases with clear cell carcinoma (CCC) and CCBT between 1984 and 2015 who received surgery at the National Defense Medical College Hospital using 2020 World Health Organization (WHO) criteria. In addition to the definition of CCBT in 2020 WHO criteria, clear cell with atypia of the glandular epithelium without fibromatous component was added to the diagnostic criteria of CCBT. Two cases with CCBT were identified through review in the current study. There were no cases that changed from the initial CCBT diagnosis that were included in the current study. Case 1 was a 43-year-old woman who received total hysterectomy, bilateral salpingo-oophorectomy and partial omentectomy. Pathologically, cysts were lined by cuboidal, hobnail and clear cells with eosinophilic cytoplasm and moderate nuclear atypia without the fibromatous component. These cells were adjacent to atypical endometriosis and non-atypical endometriosis, and the patient was diagnosed with CCBT. She exhibited no evidence of the disease for 37 months following surgery. Case 2 was a 42-year-old woman who received left salpingo-oophorectomy, partial omentectomy and pelvic lymphadenectomy. The tumor exhibited a cyst (80 mm) and nodular component. Pathologically, the tumor cells were lined by hobnail cells with mild atypia and eosinophilic cytoplasm without the fibromatous component. This patient was diagnosed with CCBT and exhibited no evidence of disease for 20 months following surgery. CCBT without fibromatous component is a rare and non-aggressive histological subtype. Additionally, regardless of fibromatous component, CCBT was able to be diagnosed.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development 2011
- Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report. 2012
- Management and Prognosis of Clear Cell Borderline Ovarian Tumor 2012
Cited by (1)
References (21)
- Borderline clear cell adenofibroma of the ovary associated with ovarian endometriosis: a case report. via openalex
- Management and Prognosis of Clear Cell Borderline Ovarian Tumor via openalex
- Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development via openalex
- W1984064010 via openalex
- W1998411917 via openalex
- W2007616930 via openalex
- W2024659202 via openalex
- W2034846334 via openalex
- W2068146814 via openalex
- W2129355295 via openalex
- W2148925749 via openalex
- W2315168846 via openalex
- W2414376955 via openalex
- W2565033598 via openalex
- W2597952575 via openalex
- W2759113178 via openalex
- W3142150957 via openalex
- W3210841801 via openalex
- W4243536311 via openalex
- W1538116381 via openalex
- W1838789601 via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:49.034193+00:00
License: CC0
· commercial use OK